AMARYL P 15 MG/1 MG TABLET
By Amaryl P
Rx
10 Tablet in a Strip

Composition
Pioglitazone(15mg) + Glimepiride(1mg)

Manufacturer - Sanofi India Ltd
Sanofi House, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400072

Expires on or after
March, 2026

liver
When it comes to your liver health, it is important to approach the use of AMARYL P 15 MG/1 MG TABLET with care. Patients with liver disease should take it with caution, as dose adjustments may be necessary. Consulting your doctor is crucial to ensure safe usage. It is advised to avoid using AMARYL P 15 MG/1 MG TABLET in cases of severe liver disease, as these patients may face the risk of very low blood sugar levels, which could eventually return to normal over time.

kidney
AMARYL P 15 MG/1 MG TABLET should be used carefully in patients with kidney issues. Adjusting the dose may be necessary, so consult your doctor. Not recommended for severe kidney disease due to potential low blood sugar levels.

alcohol
It is unsafe to consume alcohol with AMARYL P 15 MG/1 MG TABLET.

driving
"People must avoid driving with low or high blood sugar when taking AMARYL P 15 MG/1 MG TABLET."

pregnancy
AMARYL P 15 MG/1 MG TABLET is not recommended during pregnancy due to limited human studies. Animal studies suggest potential harm to the developing baby. Consult your doctor for assessing benefits and risks.

breastfeeding
AMARYL P 15 MG/1 MG TABLET is considered safe during breastfeeding. Limited human data show no significant risk to the baby. Monitoring the infant's blood glucose is recommended while the mother is taking Triofid.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹71.1
₹79
10% OFF
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025
